Fresh millions for Coldplasmatech - financing round successfully closed
We are proud to welcome investors like Marc Griefahn, Wolfgang Biedermann and the Hamburger Venture League to our circle of investors.
COLDPLASMATECH receives a mid-seven-figure euro sum in a further round of financing. The company's valuation has multiplied due to the outstanding results and the market conditions developed.
The additional capital is intended to ensure that the high demand for the novel wound therapy is met and to establish COLDPLASMATECH as the leading wound treatment with cold plasma. The first goal is now to establish COLDPLASMATECH plasma centers at strategic points in Germany to ensure basic patient care in Germany - a first step to enable nationwide treatment with the novel wound dressings. Furthermore, the investment will be used to conduct the BMBF-supported POWER study, which will demonstrate the capabilities of cold plasma in the treatment of hard-to-heal wounds in an evidence-based manner for the first time.
"Having now spent many years on the subject of cold plasma, I am not only convinced of the potential of this new medical direction, but am also investing in the form of application with the highest prospects of success and best results." M. Griefahn, Managing Director and owner of WEINMANN Emergency Medical Technology.
